Acute renal toxicity associated with suramin in the treatment of prostate cancer

W. D. Figg, M. R. Cooper, A. Thibault, D. Headlee, J. Humphrey, Raymond Bergan, E. Reed, O. Sartor

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

The use of suramin, a polysulfonated naphthylurea, in the treatment of advanced prostate cancer currently is being investigated. A 52-year-old man developed acute renal dysfunction after receiving nine doses of suramin. His suramin therapy was discontinued, but his serum creatinine level continued to rise to 10.8 mg/dl during the next 6 days. The patient was not rechallenged with suramin, and his renal function returned to baseline within the next 3 weeks. Future investigators of this drug should be aware of the possibility of such a reaction with parenteral administration.

Original languageEnglish (US)
Pages (from-to)1612-1614
Number of pages3
JournalCancer
Volume74
Issue number5
DOIs
StatePublished - 1994
Externally publishedYes

Fingerprint

Suramin
Prostatic Neoplasms
Kidney
Therapeutics
Creatinine
Research Personnel
Serum
Pharmaceutical Preparations

Keywords

  • acute renal failure
  • nephrotoxicity
  • prostate cancer
  • renal
  • suramin

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Acute renal toxicity associated with suramin in the treatment of prostate cancer. / Figg, W. D.; Cooper, M. R.; Thibault, A.; Headlee, D.; Humphrey, J.; Bergan, Raymond; Reed, E.; Sartor, O.

In: Cancer, Vol. 74, No. 5, 1994, p. 1612-1614.

Research output: Contribution to journalArticle

Figg, WD, Cooper, MR, Thibault, A, Headlee, D, Humphrey, J, Bergan, R, Reed, E & Sartor, O 1994, 'Acute renal toxicity associated with suramin in the treatment of prostate cancer', Cancer, vol. 74, no. 5, pp. 1612-1614. https://doi.org/10.1002/1097-0142(19940901)74:5<1612::AID-CNCR2820740519>3.0.CO;2-Q
Figg, W. D. ; Cooper, M. R. ; Thibault, A. ; Headlee, D. ; Humphrey, J. ; Bergan, Raymond ; Reed, E. ; Sartor, O. / Acute renal toxicity associated with suramin in the treatment of prostate cancer. In: Cancer. 1994 ; Vol. 74, No. 5. pp. 1612-1614.
@article{b2426332e30f412f8ccd50ae9d5def94,
title = "Acute renal toxicity associated with suramin in the treatment of prostate cancer",
abstract = "The use of suramin, a polysulfonated naphthylurea, in the treatment of advanced prostate cancer currently is being investigated. A 52-year-old man developed acute renal dysfunction after receiving nine doses of suramin. His suramin therapy was discontinued, but his serum creatinine level continued to rise to 10.8 mg/dl during the next 6 days. The patient was not rechallenged with suramin, and his renal function returned to baseline within the next 3 weeks. Future investigators of this drug should be aware of the possibility of such a reaction with parenteral administration.",
keywords = "acute renal failure, nephrotoxicity, prostate cancer, renal, suramin",
author = "Figg, {W. D.} and Cooper, {M. R.} and A. Thibault and D. Headlee and J. Humphrey and Raymond Bergan and E. Reed and O. Sartor",
year = "1994",
doi = "10.1002/1097-0142(19940901)74:5<1612::AID-CNCR2820740519>3.0.CO;2-Q",
language = "English (US)",
volume = "74",
pages = "1612--1614",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Acute renal toxicity associated with suramin in the treatment of prostate cancer

AU - Figg, W. D.

AU - Cooper, M. R.

AU - Thibault, A.

AU - Headlee, D.

AU - Humphrey, J.

AU - Bergan, Raymond

AU - Reed, E.

AU - Sartor, O.

PY - 1994

Y1 - 1994

N2 - The use of suramin, a polysulfonated naphthylurea, in the treatment of advanced prostate cancer currently is being investigated. A 52-year-old man developed acute renal dysfunction after receiving nine doses of suramin. His suramin therapy was discontinued, but his serum creatinine level continued to rise to 10.8 mg/dl during the next 6 days. The patient was not rechallenged with suramin, and his renal function returned to baseline within the next 3 weeks. Future investigators of this drug should be aware of the possibility of such a reaction with parenteral administration.

AB - The use of suramin, a polysulfonated naphthylurea, in the treatment of advanced prostate cancer currently is being investigated. A 52-year-old man developed acute renal dysfunction after receiving nine doses of suramin. His suramin therapy was discontinued, but his serum creatinine level continued to rise to 10.8 mg/dl during the next 6 days. The patient was not rechallenged with suramin, and his renal function returned to baseline within the next 3 weeks. Future investigators of this drug should be aware of the possibility of such a reaction with parenteral administration.

KW - acute renal failure

KW - nephrotoxicity

KW - prostate cancer

KW - renal

KW - suramin

UR - http://www.scopus.com/inward/record.url?scp=0028068481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028068481&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19940901)74:5<1612::AID-CNCR2820740519>3.0.CO;2-Q

DO - 10.1002/1097-0142(19940901)74:5<1612::AID-CNCR2820740519>3.0.CO;2-Q

M3 - Article

C2 - 8062193

AN - SCOPUS:0028068481

VL - 74

SP - 1612

EP - 1614

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 5

ER -